製品名:3-chloropropanoyl chloride

IUPAC Name:3-chloropropanoyl chloride

CAS番号:625-36-5
分子式:C3H4Cl2O
純度:95%+
カタログ番号:CM326224
分子量:126.96

包装単位 有効在庫 価格(USD) 数量
CM326224-1000g 1-2 Weeks ǶǶ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:625-36-5
分子式:C3H4Cl2O
融点:-
SMILESコード:O=C(Cl)CCCl
密度:
カタログ番号:CM326224
分子量:126.96
沸点:
MDL番号:MFCD00000747
保管方法:Keep in a tight container and store in a cool place

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

Belzutifan
On September 19, MSD announced that the U.S. FDA has accepted and granted priority review for a supplemental new drug application (sNDA) seeking approval for Welireg (Belzutifan), Merck's oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma (RCC). Welireg was the first HIF-2α inhibitor therapy approved in the U.S. and is currently approved for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated RCC, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.